Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.

Biffi M, Ammendola E, Menardi E, Parisi Q, Narducci ML, De Filippo P, Manzo M, Stabile G, Potenza DR, Zanon F, Quartieri F, Rillo M, Saporito D, Zacà V, Berisso MZ, Bertini M, Tumietto F, Malacrida M, Diemberger I.

Europace. 2019 Jun 17. pii: euz166. doi: 10.1093/europace/euz166. [Epub ahead of print]

PMID:
31209482
2.

Time to therapy delivery and effectiveness of the subcutaneous implantable cardioverter-defibrillator.

Diemberger I, Migliore F, Ricciardi G, Ottaviano L, Tavoletta V, Francia P, Viani S, Capucci A, de Filippo P, Nigro G, Caravati F, Palmisano P, Ziacchi M, Lovecchio M, Valsecchi S, Bongiorni MG, Biffi M; “S-ICD Rhythm Detect” Investigators.

Heart Rhythm. 2019 May 29. pii: S1547-5271(19)30538-7. doi: 10.1016/j.hrthm.2019.05.028. [Epub ahead of print]

PMID:
31150817
3.

Wireless Endocardial Atrial (and Ventricular) Sensing with no Implanted Power Source: a Proposal.

Corazza I, Diemberger I, Martignani C, Ziacchi M, Rossi PL, Lombi A, Zannoli R, Biffi M.

J Med Syst. 2019 Apr 26;43(6):159. doi: 10.1007/s10916-019-1277-6.

PMID:
31028553
4.

Anomalous Coronary Artery Origin and Sudden Cardiac Death: Clinical and Pathological Insights From a National Pathology Registry.

Finocchiaro G, Behr ER, Tanzarella G, Papadakis M, Malhotra A, Dhutia H, Miles C, Diemberger I, Sharma S, Sheppard MN.

JACC Clin Electrophysiol. 2019 Apr;5(4):516-522. doi: 10.1016/j.jacep.2018.11.015. Epub 2019 Jan 30.

PMID:
31000108
5.

Successful defibrillation verification in subcutaneous implantable cardioverter-defibrillator recipients by low-energy shocks.

Biffi M, Ziacchi M, Angeletti A, Castelli A, Massaro G, Martignani C, Lovecchio M, Valsecchi S, Diemberger I.

Clin Cardiol. 2019 Jun;42(6):612-617. doi: 10.1002/clc.23184. Epub 2019 Apr 25.

6.

Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients.

Proietti M, Farcomeni A, Romiti GF, Di Rocco A, Placentino F, Diemberger I, Lip GY, Boriani G.

Eur J Prev Cardiol. 2018 Dec 6:2047487318817662. doi: 10.1177/2047487318817662. [Epub ahead of print]

PMID:
30861693
7.

Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry.

Migliore F, Viani S, Bongiorni MG, Zorzi A, Silvetti MS, Francia P, D'Onofrio A, De Franceschi P, Sala S, Donzelli S, Ricciardi G, Menardi E, Giammaria M, La Greca C, Bauce B, Rigato I, Iliceto S, Bertaglia E, Diemberger I, Corrado D.

Int J Cardiol. 2019 Apr 1;280:74-79. doi: 10.1016/j.ijcard.2019.01.041. Epub 2019 Jan 12.

8.

Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation.

Corponi F, Fabbri C, Boriani G, Diemberger I, Albani D, Forloni G, Serretti A.

Neuropsychobiology. 2019;77(2):67-72. doi: 10.1159/000493400. Epub 2018 Dec 13.

PMID:
30544110
9.

Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.

Viani S, Migliore F, Tola G, Pisanò ECL, Russo AD, Luzzi G, Sartori P, Piro A, Rordorf R, Forleo GB, Rago A, Segreti L, Bertaglia E, Biffi M, Lovecchio M, Valsecchi S, Diemberger I, Bongiorni MG.

Heart Rhythm. 2019 Apr;16(4):564-571. doi: 10.1016/j.hrthm.2018.10.026. Epub 2018 Oct 24.

PMID:
30366163
10.

Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System.

Mei R, Raschi E, Forcesi E, Diemberger I, De Ponti F, Poluzzi E.

Int J Cardiol. 2018 Dec 15;273:183-186. doi: 10.1016/j.ijcard.2018.09.054. Epub 2018 Sep 14. No abstract available.

PMID:
30236504
11.

Leadless left ventricular endocardial pacing: a real alternative or a luxury for a few?

De Maria E, Ziacchi M, Diemberger I, Biffi M.

Cardiovasc Diagn Ther. 2018 Aug;8(4):530-533. doi: 10.21037/cdt.2018.03.08. No abstract available.

12.

Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study.

Diemberger I, Bonfiglioli R, Martignani C, Graziosi M, Biffi M, Lorenzetti S, Ziacchi M, Nanni C, Fanti S, Boriani G.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):194-205. doi: 10.1007/s00259-018-4142-9. Epub 2018 Sep 8.

PMID:
30196365
13.

Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads.

Ziacchi M, Diemberger I, Corzani A, Martignani C, Mazzotti A, Massaro G, Valzania C, Rapezzi C, Boriani G, Biffi M.

Sci Rep. 2018 Sep 5;8(1):13262. doi: 10.1038/s41598-018-31692-z.

14.

Meta-analysis of Clinical Outcomes of Electrical Cardioversion and Catheter Ablation in Patients with Atrial Fibrillation and Chronic Kidney Disease.

Diemberger I, Genovesi S, Massaro G, Reggiani MLB, Frisoni J, Gorlato G, Mauro E, Padeletti M, Vincenti A, Boriani G.

Curr Pharm Des. 2018;24(24):2794-2801. doi: 10.2174/1381612824666180829112019.

PMID:
30156153
15.

Cardiac resynchronization therapy in the real world: need to upgrade outcome research.

Boriani G, Diemberger I.

Eur J Heart Fail. 2018 Oct;20(10):1469-1471. doi: 10.1002/ejhf.1288. Epub 2018 Aug 23. No abstract available.

PMID:
30141221
16.

Reporting of immune checkpoint inhibitor-associated myocarditis.

Raschi E, Diemberger I, Poluzzi E, De Ponti F.

Lancet. 2018 Aug 4;392(10145):383. doi: 10.1016/S0140-6736(18)31549-6. No abstract available.

PMID:
30102168
17.

Drug-induced Kounis syndrome: A matter of pharmacovigilance.

Raschi E, Fertonani Affini L, Antonazzo IC, Diemberger I, Poluzzi E, De Ponti F.

Int J Cardiol. 2019 Jan 1;274:381. doi: 10.1016/j.ijcard.2018.07.119. Epub 2018 Jul 24. No abstract available.

PMID:
30057169
18.

Is ventricular sensing always right, when it is left?

Biffi M, de Zan G, Massaro G, Angeletti A, Martignani C, Boriani G, Diemberger I, Ziacchi M.

Clin Cardiol. 2018 Sep;41(9):1238-1245. doi: 10.1002/clc.23033. Epub 2018 Sep 21.

19.

A closer look into the complexity of our practice: Outcome research for transvenous temporary cardiac pacing.

Boriani G, Diemberger I.

Int J Cardiol. 2018 Nov 15;271:117-118. doi: 10.1016/j.ijcard.2018.07.039. Epub 2018 Jul 6. No abstract available.

PMID:
30025654
20.

Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.

Boriani G, Proietti M, Laroche C, Diemberger I, Popescu MI, Riahi S, Shantsila A, Dan GA, Tavazzi L, Maggioni AP, Lip GYH; EORP-AF Pilot General Registry Investigators.

Int J Cardiol. 2018 Nov 15;271:68-74. doi: 10.1016/j.ijcard.2018.05.034. Epub 2018 Jul 9.

PMID:
30001945
21.

Recurrence of pericarditis after influenza vaccination: a case report and review of the literature.

Mei R, Raschi E, Poluzzi E, Diemberger I, De Ponti F.

BMC Pharmacol Toxicol. 2018 May 5;19(1):20. doi: 10.1186/s40360-018-0211-8. Review.

22.

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-authors' reply.

Raschi E, Diemberger I, Cosmi B, De Ponti F.

Intern Emerg Med. 2018 Jun;13(4):635-636. doi: 10.1007/s11739-018-1853-7. Epub 2018 Apr 25. No abstract available.

PMID:
29696520
23.

The struggle against infections of cardiac implantable electrical devices: the burden of costs requires new personalized solutions.

Boriani G, Elsner C, Diemberger I.

Europace. 2018 Dec 1;20(12):1877-1879. doi: 10.1093/europace/euy049. No abstract available.

PMID:
29672698
24.

Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?

Boriani G, Ziacchi M, Nesti M, Battista A, Placentino F, Malavasi VL, Diemberger I, Padeletti L.

Int J Cardiol. 2018 Jun 15;261:119-129. doi: 10.1016/j.ijcard.2018.01.039. Review.

PMID:
29657035
25.

Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care.

Diemberger I, Fantecchi E, Reggiani MLB, Martignani C, Angeletti A, Massaro G, Ziacchi M, Biffi M, Lip GYH, Boriani G.

Int J Cardiol. 2018 Jun 15;261:73-77. doi: 10.1016/j.ijcard.2018.03.058. Epub 2018 Mar 14.

PMID:
29572083
26.

External implantable defibrillator as a bridge to reimplant after explant for infection: Experience from two centers.

Dell'Era G, Ziacchi M, Prenna E, Diemberger I, Varalda M, Martignani C, Guerra F, Biffi M, Occhetta E.

Pacing Clin Electrophysiol. 2018 May;41(5):532-535. doi: 10.1111/pace.13320. Epub 2018 Apr 15.

PMID:
29518264
27.

Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Meeder J, Kurpesa M, Baluta MM, Proietti M, Tavazzi L, Maggioni AP, Lip GYH; EORP-AF General Pilot Registry Investigators.

J Cardiovasc Electrophysiol. 2018 Apr;29(4):566-572. doi: 10.1111/jce.13428. Epub 2018 Feb 1.

PMID:
29345382
28.

The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study.

Diemberger I, Migliore F, Biffi M, Cipriani A, Bertaglia E, Lorenzetti S, Massaro G, Tanzarella G, Boriani G.

Int J Cardiol. 2018 Jan 1;250:146-149. doi: 10.1016/j.ijcard.2017.07.061. Epub 2017 Oct 9.

PMID:
29032885
29.

Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study.

D'Onofrio A, La Rovere MT, Emdin M, Capucci A, Sinagra G, Bianchi V, Pisanò ECL, Pieragnoli P, Tespili M, Luzi M, Talarico A, Zecchin M, Rapacciuolo A, Piacenti M, Indolfi C, Arias MA, Diemberger I, Checchinato C, Boriani G, Padeletti L.

Heart Rhythm. 2018 Feb;15(2):211-217. doi: 10.1016/j.hrthm.2017.09.038. Epub 2017 Oct 7.

30.

Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry.

Boriani G, Proietti M, Laroche C, Fauchier L, Marin F, Nabauer M, Potpara T, Dan GA, Kalarus Z, Diemberger I, Tavazzi L, Maggioni AP, Lip GYH; EORP-AF Long-Term General Registry Investigators; Steering Committee (National Coordinators).

Europace. 2018 May 1;20(5):747-757. doi: 10.1093/europace/eux301.

PMID:
29016832
31.

Predictors of long-term survival free from relapses after extraction of infected CIED.

Diemberger I, Biffi M, Lorenzetti S, Martignani C, Raffaelli E, Ziacchi M, Rapezzi C, Pacini D, Boriani G.

Europace. 2018 Jun 1;20(6):1018-1027. doi: 10.1093/europace/eux121.

PMID:
29016771
32.

Less is more: Can we achieve cardiac resynchronization with 2 leads only?

Biffi M, Massaro G, Candelora A, Angeletti A, Valzania C, Martignani C, Grassini D, Diemberger I, Ziacchi M.

Int J Cardiol. 2017 Dec 15;249:184-190. doi: 10.1016/j.ijcard.2017.09.189. Epub 2017 Sep 24.

PMID:
28966043
33.

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations.

Raschi E, Diemberger I, Cosmi B, De Ponti F.

Intern Emerg Med. 2018 Jan;13(1):1-9. doi: 10.1007/s11739-017-1755-0. Epub 2017 Sep 23.

PMID:
28942550
34.

Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies.

Diemberger I, Raschi E, Trifirò G.

Clin Drug Investig. 2017 Oct;37(10):985-988. doi: 10.1007/s40261-017-0563-7. No abstract available.

PMID:
28831689
35.

Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project.

Poluzzi E, Diemberger I, De Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Pilgaard Ulrichsen S, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G.

Eur J Clin Pharmacol. 2017 Nov;73(11):1499-1510. doi: 10.1007/s00228-017-2317-0. Epub 2017 Aug 22.

PMID:
28831527
36.

Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels.

Valzania C, Biffi M, Bonfiglioli R, Fallani F, Martignani C, Diemberger I, Ziacchi M, Frisoni J, Tomasi L, Fanti S, Rapezzi C, Boriani G.

J Nucl Cardiol. 2019 Feb;26(1):123-132. doi: 10.1007/s12350-017-0971-3. Epub 2017 Jun 30.

PMID:
28667454
37.

The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies.

Boriani G, Lorenzetti S, Cerbai E, Oreto G, Bronzetti G, Malavasi VL, Biffi A, Padeletti L, Botto G, Diemberger I.

Europace. 2017 Sep 1;19(9):1418-1426. doi: 10.1093/europace/eux068. Review.

PMID:
28525585
38.

The effects of gender on electrical therapies for the heart: procedural considerations, results and complications: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC).

Diemberger I, Marazzi R, Casella M, Vassanelli F, Galimberti P, Luzi M, Borrelli A, Soldati E, Golzio PG, Fumagalli S, Francia P, Padeletti L, Botto G, Boriani G.

Europace. 2017 Dec 1;19(12):1911-1921. doi: 10.1093/europace/eux034. Review.

PMID:
28520959
39.

Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only?

Biffi M, Massaro G, Diemberger I, Martignani C, Corzani A, Ziacchi M.

HeartRhythm Case Rep. 2016 Oct 19;3(1):30-32. doi: 10.1016/j.hrcr.2016.08.004. eCollection 2017 Jan. No abstract available.

40.

Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.

Proietti M, Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Sinagra G, Dan GA, Maggioni AP, Tavazzi L, Lane DA, Lip GYH; EORP-AF General Pilot Registry Investigators.

Europace. 2017 Apr 1;19(4):535-543. doi: 10.1093/europace/euw150.

PMID:
28431068
41.

Cardiac resynchronization therapy in the real world: need to focus on implant rates, patient selection, co-morbidities, type of devices, and complications.

Boriani G, Diemberger I.

Eur Heart J. 2017 Jul 14;38(27):2129-2131. doi: 10.1093/eurheartj/ehx137. No abstract available.

PMID:
28430905
42.

Use of azithromycin and risk of ventricular arrhythmia.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM.

CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355.

43.

Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice.

Poluzzi E, Raschi E, Diemberger I, De Ponti F.

Drug Saf. 2017 Jun;40(6):461-464. doi: 10.1007/s40264-017-0529-y. No abstract available.

PMID:
28389980
44.

Oral loading of propafenone: restoring its role before restoring rhythm.

Martignani C, Diemberger I, Ziacchi M, Biffi M, Boriani G.

Europace. 2017 Nov 1;19(11):1903. doi: 10.1093/europace/euw264. No abstract available.

PMID:
28371925
45.

Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes.

Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, Crijns HJ, Tavazzi L, Maggioni AP, Lip GY.

Sci Rep. 2017 Feb 22;7:42379. doi: 10.1038/srep42379. No abstract available.

46.

Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.

Fabbri C, Boriani G, Diemberger I, Filippi MG, Ravegnini G, Hrelia P, Minarini A, Albani D, Forloni G, Angelini S, Serretti A.

Basic Clin Pharmacol Toxicol. 2017 May;120(5):482-490. doi: 10.1111/bcpt.12720. Epub 2017 Jan 5.

47.

Outcomes with Dronedarone in Atrial Fibrillation: What Differences Between Real-World Practice and Trials? A Meta-Analysis and Meta-Regression Analysis.

Diemberger I, Massaro G, Reggiani MLB, Lorenzetti S, Biffi M, Ziacchi M, Martignani C, Boriani G.

Curr Pharm Des. 2017;23(6):944-951. doi: 10.2174/1381612822666161006141512. Review.

PMID:
27719634
48.

Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes.

Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, Crijns HJGM, Tavazzi L, Maggioni AP, Lip GYH.

Sci Rep. 2016 Jul 28;6:30271. doi: 10.1038/srep30271. Erratum in: Sci Rep. 2017 Feb 22;7:42379.

49.

Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry.

Biffi M, Bertini M, Saporito D, Belotti G, Quartieri F, Piancastelli M, Pucci A, Boggian G, Mazzocca GF, Giorgi D, Diotallevi P, Diemberger I, Martignani C, Pancaldi S, Ziacchi M, Marcantoni L, Toselli T, Attala S, Iori M, Bottoni N, Argnani S, Tomasi C, Sassone B, Boriani G.

Europace. 2016 Oct;18(10):1551-1560. Epub 2016 Jun 14.

PMID:
27305923
50.

Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise.

Ziacchi M, Corzani A, Diemberger I, Martignani C, Marziali A, Mazzotti A, Massaro G, Rapezzi C, Biffi M, Boriani G.

Heart Lung Circ. 2016 May;25(5):476-83. doi: 10.1016/j.hlc.2015.10.016. Epub 2015 Nov 18.

PMID:
27044657

Supplemental Content

Loading ...
Support Center